Synergistic modulation of the gut microbiome-liver-host metabolome axis associates with the therapeutic efficacy of Danlou tablet against metabolic syndrome
Minghe Yao, Xun Li, Lingling Li, Haifeng Yan, Xiaohui Li, Erping Xu, Hongru Zhou · 2026
Read Synergistic modulation of the gut microbiome-liver-host metabolome axis associates with the therapeutic efficacy of Danlou tablet against metabolic syndrome by Minghe Yao, Xun Li, Lingling Li, Haifeng Yan, Xiaohui Li, Erping Xu, Hongru Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13329814.txt.
Description
Minghe Yao and colleagues test a traditional Chinese formula against diet-driven metabolic harm in mice in a 2026 study. Danlou tablet is used for heart disease care and adjusts fat handling, so the team asked whether it also counters obesity and insulin resistance. Mice ate a high-fat diet for 22 weeks, with treatment given during that span.
Treated mice gained less weight and fat, handled glucose better, and showed less liver fat, swelling, and oxidative stress in the reported checks. Gut microbe balance moved back toward normal, with shifts in key groups. Blood and liver data linked gains to restored fat burning in the liver and calmer immune pathways. The authors frame the effect as acting through the gut and liver link.
Catalog record
| CREATOR | Minghe Yao, Xun Li, Lingling Li, Haifeng Yan, Xiaohui Li, Erping Xu, Hongru Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66463 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |